Neurocrine Biosciences Inc (NBIX)
134.22
-1.20
(-0.89%)
USD |
NASDAQ |
Dec 23, 10:39
Neurocrine Biosciences Total Assets (Quarterly): 3.535B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Repligen Corp | 2.831B |
| West Pharmaceutical Services Inc | 3.675B |
| AptarGroup Inc | 4.625B |
| The Cooper Companies Inc | 12.32B |
| AIM ImmunoTech Inc | 13.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 816.10M |
| Shareholders Equity (Quarterly) | 2.719B |
| Current Ratio | 4.367 |
| Net Debt Paydown Yield | 0.29% |